Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02942199 · ClinicalTrials.gov registry record · NA
MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)
A NA study, sponsored by Cambridge Health Alliance.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02942199 is a NA study that has completed, run by Cambridge Health Alliance. The registered enrollment target is 12 participants.
The verdict
NCT02942199, a NA study, has completed, sponsored by Cambridge Health Alliance.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of the MyMOBILE study is to evaluate the feasibility, acceptability, and usability of a novel platform that integrates text messaging reminders, secure electronic pill organizers, and daily remote brief motivational recovery support visits with a standardized protocol for supervised self-administration of buprenorphine via videoconferencing.
Interventions
- OTHER MySafeRx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02942199
The ClinicalTrials.gov registry entry for NCT02942199 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cambridge Health Alliance, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MySafeRx is the first listed.
NCT02942199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02942199 about?
NCT02942199 is a clinical study titled "MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)". The goal of the MyMOBILE study is to evaluate the feasibility, acceptability, and usability of a novel platform that integrates text messaging reminders, secure electronic pill organizers, and daily remote brief motivational recovery support visits with a standardized protocol for supervised self-ad...
What is the current status of trial NCT02942199?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-11. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT02942199?
The interventions under investigation include: MySafeRx (OTHER).
Who is sponsoring clinical trial NCT02942199?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.